• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在抗神经节苷脂抗体介导的神经病变中,大自然不会跳跃。

Natura non facit saltus in anti-ganglioside antibody-mediated neuropathies.

机构信息

Department of Neuroscience and Imaging, University "G. d'Annunzio,", Chieti-Pescara, Italy.

出版信息

Muscle Nerve. 2013 Oct;48(4):484-7. doi: 10.1002/mus.23881.

DOI:10.1002/mus.23881
PMID:23625341
Abstract

Natura non facit saltus (Latin for "nature does not make jumps") is a maxim expressing the idea that natural things and properties change gradually, in a continuum, rather than suddenly. In biomedical sciences, for taxonomic purposes, we make jumps that emphasize differences more than similarities. Among the dysimmune neuropathies, 2 disorders, characterized by the presence of antibodies to gangliosides GM1 and GD1a and a peculiar, exclusive motor involvement, have been identified: acute motor axonal neuropathy (AMAN) and multifocal motor neuropathy (MMN). However, anti-GM1 or -GD1a antibodies are also associated with acute motor and sensory axonal motor neuropathy (AMSAN). We review the results of recent clinical and experimental studies showing that AMAN and MMN are not exclusively motor. We discuss the possible explanations for the greater resistance of sensory fibers to antibody attack to finally suggest that AMAN, AMSAN, and MMN belong to a continuous spectrum with a common pathophysiological mechanism.

摘要

自然不跳跃(拉丁语为“nature does not make jumps”)是一个表达自然事物和属性逐渐变化的格言,在一个连续体中,而不是突然变化。在生物医学科学中,出于分类目的,我们会做出强调差异而不是相似性的跳跃。在免疫失调性神经病中,已经确定了 2 种疾病,其特征是存在针对神经节苷脂 GM1 和 GD1a 的抗体以及独特的、排他性的运动受累:急性运动轴索性神经病(AMAN)和多灶性运动神经病(MMN)。然而,抗-GM1 或 -GD1a 抗体也与急性运动感觉轴索性神经病(AMSAN)相关。我们回顾了最近的临床和实验研究结果,这些结果表明 AMAN 和 MMN 不仅仅是运动性的。我们讨论了感觉纤维对抗体攻击更具抵抗力的可能解释,最终建议 AMAN、AMSAN 和 MMN 属于具有共同病理生理机制的连续谱。

相似文献

1
Natura non facit saltus in anti-ganglioside antibody-mediated neuropathies.在抗神经节苷脂抗体介导的神经病变中,大自然不会跳跃。
Muscle Nerve. 2013 Oct;48(4):484-7. doi: 10.1002/mus.23881.
2
A common mechanism and a new categorization for anti-ganglioside antibody-mediated neuropathies.抗神经节苷脂抗体介导的神经病变的共同机制和新分类。
Exp Neurol. 2012 Jun;235(2):513-6. doi: 10.1016/j.expneurol.2012.03.023. Epub 2012 Apr 6.
3
Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies.郎飞结功能障碍:抗神经节苷脂抗体介导的神经病变的一种机制。
Exp Neurol. 2012 Jan;233(1):534-42. doi: 10.1016/j.expneurol.2011.11.039. Epub 2011 Dec 8.
4
Acute motor axonal neuropathy and acute motor-sensory axonal neuropathy share a common immunological profile.急性运动轴索性神经病和急性运动感觉轴索性神经病具有共同的免疫学特征。
J Neurol Sci. 1999 Oct 15;168(2):121-6. doi: 10.1016/s0022-510x(99)00180-x.
5
Cerebellar ataxia and acute motor axonal neuropathy associated with Anti GD1b and Anti GM1 antibodies.与抗GD1b和抗GM1抗体相关的小脑共济失调和急性运动轴索性神经病。
J Clin Neurosci. 2005 Sep;12(7):808-10. doi: 10.1016/j.jocn.2004.09.019.
6
Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies.神经节苷脂抗体介导的神经病中的脱髓鞘和轴突分类之外:结节性副节段病。
Clin Neurophysiol. 2013 Oct;124(10):1928-34. doi: 10.1016/j.clinph.2013.03.025. Epub 2013 Apr 30.
7
How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?抗神经IgM抗体在慢性免疫介导性神经病的诊断中有多大作用?
J Neurol Sci. 2008 Mar 15;266(1-2):156-63. doi: 10.1016/j.jns.2007.09.020. Epub 2007 Oct 2.
8
[Antiganglioside antibodies: when, which and for what].[抗神经节苷脂抗体:何时检测、检测哪种以及为何检测]
Neurologia. 2001 Aug-Sep;16(7):293-7.
9
Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies.抗神经节苷脂复合物 IgM 抗体在多灶性运动神经病和慢性免疫介导性神经病中的作用。
J Neuroimmunol. 2010 Feb 26;219(1-2):119-22. doi: 10.1016/j.jneuroim.2009.11.012. Epub 2009 Dec 16.
10
Structural requirements of anti-GD1a antibodies determine their target specificity.抗GD1a抗体的结构要求决定了它们的靶标特异性。
Brain. 2008 Jul;131(Pt 7):1926-39. doi: 10.1093/brain/awn074. Epub 2008 May 16.

引用本文的文献

1
Antiganglioside antibody frequency in routine clinical care settings.抗神经节苷脂抗体在常规临床诊疗环境中的出现频率。
Eur J Neurol. 2024 Jul;31(7):e16290. doi: 10.1111/ene.16290. Epub 2024 Mar 31.
2
Multifocal motor neuropathy occurring after acute motor axonal neuropathy: two stages of the same disease?急性运动轴索性神经病后发生的多灶性运动神经病:同一种疾病的两个阶段?
Neurol Sci. 2022 Feb;43(2):1463-1465. doi: 10.1007/s10072-021-05725-x. Epub 2021 Nov 20.
3
Pathological Findings in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Single-Center Experience.
慢性炎症性脱髓鞘性多发性神经根神经病的病理发现:单中心经验
Brain Sci. 2020 Jun 17;10(6):383. doi: 10.3390/brainsci10060383.
4
Complement activity is associated with disease severity in multifocal motor neuropathy.补体活性与多灶性运动神经病的疾病严重程度相关。
Neurol Neuroimmunol Neuroinflamm. 2015 Jun 25;2(4):e119. doi: 10.1212/NXI.0000000000000119. eCollection 2015 Aug.
5
Optimizing IgG therapy in chronic autoimmune neuropathies: a hypothesis driven approach.优化慢性自身免疫性神经病中的免疫球蛋白治疗:一种基于假设的方法。
Muscle Nerve. 2015 Mar;51(3):315-26. doi: 10.1002/mus.24526. Epub 2015 Jan 29.